These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24011176)

  • 21. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glucuronidation of antitumour therapeutics--detoxification, mechanism of resistance or prodrug formation?].
    Mróz A; Mazerska Z
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1462-77. PubMed ID: 27259218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo.
    Malfatti MA; Ubick EA; Felton JS
    Carcinogenesis; 2005 Nov; 26(11):2019-28. PubMed ID: 15944213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
    Nakamori F; Naritomi Y; Hosoya K; Moriguchi H; Tetsuka K; Furukawa T; Kadono K; Yamano K; Terashita S; Teramura T
    Drug Metab Dispos; 2012 Sep; 40(9):1771-7. PubMed ID: 22685216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
    Katoh M; Matsui T; Yokoi T
    Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
    Knights KM; Miners JO
    Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
    Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
    Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of UDP-glucuronosyltransferases active on steroid hormones.
    Hum DW; Bélanger A; Lévesque E; Barbier O; Beaulieu M; Albert C; Vallée M; Guillemette C; Tchernof A; Turgeon D; Dubois S
    J Steroid Biochem Mol Biol; 1999; 69(1-6):413-23. PubMed ID: 10419020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice.
    Buckley DB; Klaassen CD
    Drug Metab Dispos; 2007 Jan; 35(1):121-7. PubMed ID: 17050650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
    Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
    Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
    Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
    Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
    Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
    Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention.
    Saracino MR; Lampe JW
    Nutr Cancer; 2007; 59(2):121-41. PubMed ID: 18001207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uridine Diphosphate-Glucuronosyltransferase (UGT) 2B Subfamily Interspecies Differences in Carnivores.
    Kondo T; Ikenaka Y; Nakayama SMM; Kawai YK; Mizukawa H; Mitani Y; Nomiyama K; Tanabe S; Ishizuka M
    Toxicol Sci; 2017 Jul; 158(1):90-100. PubMed ID: 28453659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol.
    Dong RH; Fang ZZ; Zhu LL; Ge GB; Yang L; Liu ZY
    Xenobiotica; 2012 Oct; 42(10):1009-16. PubMed ID: 22559213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of drug metabolizing enzymes in clearance.
    Di L
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):379-93. PubMed ID: 24392841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.